1. Follow the LEADER—Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results Trial

   • Sanjay Kalra

   Commentary Open access 09 September 2016 Pages: 601 - 609

2. A Practical Approach to Glucose Abnormalities in Cystic Fibrosis

   • Gregory C. Jones
   • Christopher A. R. Sainsbury

   Review Open access 17 October 2016 Pages: 611 - 620

3. Strategies for Diabetes Management: Using Newer Oral Combination Therapies Early in the Disease

   • Joel Zonszein
   • Per-Henrik Groop

   Review Open access 31 October 2016 Pages: 621 - 639

   

4. Initiation and Intensification Strategies in Type 2 Diabetes Management: A Comparison of Basal Plus and Premix Regimens

   • Michelle Downie
   • Gary Kilov
   • Jencia Wong

   Review Open access 22 September 2016 Pages: 641 - 657

5. Canagliflozin: Efficacy and Safety in Combination with Metformin Alone or with Other Antihyperglycemic Agents in Type 2 Diabetes

   • Rong Qiu
   • Dainius Balis
   • Gary Meininger

   Review Open access 12 October 2016 Pages: 659 - 678

   

6. Simvastatin Rapidly and Reversibly Inhibits Insulin Secretion in Intact Single-Islet Cultures

   • Valentina Scattolini
   • Camilla Luni
   • Gian Paolo Fadini

   Original Research Open access 09 November 2016 Pages: 679 - 693

   

7. Glycated Hemoglobin, Body Weight and Blood Pressure in Type 2 Diabetes Patients Initiating Dapagliflozin Treatment in Primary Care: A Retrospective Study

   • John Wilding
   • Clifford Bailey
   • Cathy Emmas

   Original Research Open access 01 September 2016 Pages: 695 - 711

   

8. Development of Insulin Detemir/Insulin Aspart Cross-Reacting Antibodies Following Treatment with Insulin Detemir: 104-week Study in Children and Adolescents with Type 1 Diabetes Aged 2–16 Years

   • Nandu Thalange
   • Abdullah Bereket
   • Valentina Peterkova

   Original Research Open access 06 September 2016 Pages: 713 - 724

   

9. Incretin-Based Therapy and Risk of Pancreatic Cancer in Patients with Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Controlled Trials

   • Han Chen
   • Xiaoying Zhou
   • Guoxin Zhang

   Original Research Open access 21 September 2016 Pages: 725 - 742

   

10. Blood Glucagon Levels Predict the Hemoglobin A1c Response to Saxagliptin in Patients with Type 2 Diabetes Inadequately Controlled with Metformin

    • Hao Liu
    • Yun Hu
    • Jian-hua Ma

    Original Research Open access 12 October 2016 Pages: 743 - 753

    

11. Medication Adherence Contributes to an Improved Quality of Life in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study

    • Sofa D. Alfian
    • Hadyana Sukandar
    • Rizky Abdulah

    Original Research Open access 07 October 2016 Pages: 755 - 764

    

12. Clinical Effectiveness and Impact on Insulin Therapy Cost After Addition of Dapagliflozin to Patients with Uncontrolled Type 2 Diabetes

    • Bhavana Sosale
    • Aravind Sosale
    • Arpandev Bhattacharyya

    Original Research Open access 19 October 2016 Pages: 765 - 776

    

13. Lixisenatide Improves Glycemic Control in Asian Type 2 Diabetic Patients Inadequately Controlled With Oral Antidiabetic Drugs: An Individual Patient Data Meta-Analysis

    • Hua Shu
    • Li-na Gu
    • Ju-ming Lu

    Original Research Open access 31 October 2016 Pages: 777 - 792

14. Basal-bolus Therapy in Patients with Type 2 Diabetes Mellitus in the UK: Patient Characteristics, Treatment Patterns and the Effect of Switching to Premixed Insulin

    • Kate van Brunt
    • Bradley Curtis
    • Mireia Raluy-Callado

    Original Research Open access 31 October 2016 Pages: 793 - 807

    

15. Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart in Patients with Type 2 Diabetes from a Danish Health-Care Perspective

    • Marc Evans
    • Jens Gundgaard
    • Brian Bekker Hansen

    Original Research Open access 23 August 2016 Pages: 809 - 823

    

16. The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-on Therapy to Metformin in Patients with Uncontrolled Type 2 Diabetes Mellitus

    • Jason Gordon
    • Phil McEwan
    • Jorge Puelles

    Original Research Open access 27 October 2016 Pages: 825 - 845

    

17. Letter to the Editor Regarding: Patterns and Impact of Hypoglycemia, Hyperglycemia, and Glucose Variability on Inpatients with Insulin-Treated Cystic Fibrosis-Related Diabetes

    • John Scott Baird

    Letter Open access 04 October 2016 Pages: 847 - 847